Assignee
KALA PHARMACEUTICALS INC
US·54 granted patents·13 pending applications·212 citations·filing 2005–2022
Top patents by PatentIndex Score
67 records- 0198US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0298US8354476B2Functionalized poly(ether-anhydride) block copolymersKALA PHARMACEUTICALS INC·Filed 2005·Granted Jan 15, 2013·54 cites·26 claims
- 0395US11318088B2Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2020·Granted May 3, 2022·3 cites·22 claims
- 0495US9458169B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·22 cites·23 claims
- 0594US9790232B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Oct 17, 2017·12 cites·20 claims
- 0693US9353122B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·14 cites·50 claims
- 0791US10160765B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·7 cites·15 claims
- 0890US10618906B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·2 cites·14 claims
- 0989US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 1087US9877970B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·4 cites·26 claims
- 1187US9580421B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·4 cites·20 claims
- 1286US10398703B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Sep 3, 2019·3 cites·26 claims
- 1385US10758539B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·1 cites·23 claims
- 1485US10336767B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·3 cites·8 claims
- 1584US11104685B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Aug 31, 2021·1 cites·6 claims
- 1684US10688041B2Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 23, 2020·2 cites·33 claims
- 1783US10626121B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 21, 2020·1 cites·8 claims
- 1883US9861634B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 9, 2018·2 cites·21 claims
- 1983US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 2083US9353123B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·3 cites·35 claims
- 2182US9827248B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·2 cites·21 claims
- 2282US9688688B2Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·2 cites·16 claims
- 2382US9212145B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Dec 15, 2015·3 cites·80 claims
- 2481US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 2581US2023116686A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2680US9988386B2Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Jun 5, 2018·3 cites·23 claims
- 2779US10059693B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·29 claims
- 2879US10059692B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·1 cites·31 claims
- 2978US9802922B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Oct 31, 2017·1 cites·12 claims
- 3076US11713323B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·0 cites·10 claims
- 3175US2021355136A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3274US11369611B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·0 cites·9 claims
- 3374US11352343B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 3474US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 3574US2022106326A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3674US2021393641A1Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3773US10975090B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2020·Granted Apr 13, 2021·0 cites·12 claims
- 3872US10966987B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·21 claims
- 3972US2021380588A1Novel Compounds and Uses ThereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4071US10723719B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·20 claims
- 4171US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4270US11021487B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Jun 1, 2021·0 cites·17 claims
- 4369US10954244B2Compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 4468US10766907B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 4568US10329280B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·20 claims
- 4668US10316022B2Urea derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·18 claims
- 4768US10285991B2Therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·0 cites·26 claims
- 4868US10253036B2Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·0 cites·7 claims
- 4968US2021261562A1Crystalline forms of therapeutic compounds and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5067US10875857B21-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereofKALA PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·0 cites·15 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →